Skip to main content
. Author manuscript; available in PMC: 2016 Sep 23.
Published in final edited form as: Crit Care Clin. 2015 Jul;31(3):533–550. doi: 10.1016/j.ccc.2015.03.007

Table 3.

Pulmonary function and lung volume alterations accompanying neuromuscular weakness

Pulmonary function/Lung volume Effect
Residual Volume (RV) ↑ (with expiratory muscle weakness
Vital Capacity (VC) Initially normal, ↓after max pressures ↓50%
Total lung Capacity(TLC) ↓ (inspiratory weakness)
Functional Residual Capacity (FRC) ↓ (inspiratory weakness)
FEV1/FVC Normal (proportional ↓ FEV1 & FVC in inspiratory weakness)
Residual Volume (RV) ↑ (with expiratory muscle weakness)
Peak Expiratory Flow (PEF) Maximum Voluntary ventilation (MVV) ↓ (NM weakness or effort)
Diffusing Capacity (DLco) Normal (unless infiltrative/parenchymal process)
Maximal Inspiratory Pressure MIP ↓ (more than MEP in diaphragmatic weakness, effort)
Maximal Expiratory Pressure MEP ↓ (NM weakness, effort)